Dr. Eileen O'Reilly

Dr. Eileen M. O'Reilly is the Winthrop Rockefeller Endowed Chair in Medical Oncology at MSK, Chief of Hepatopancreaticobiliary and Neuroendocrine Cancers, and Chief of the Gastrointestinal Oncology Service, David M. Rubenstein Center for Pancreatic Cancer Co-Director, Attending Physician, Member, Memorial Sloan Kettering Cancer Center, and Professor of Medicine, Weill Cornell Medical College. She is among the world's top experts on pancreatic and hepatobiliary cancers.

• Professional Background

  • 30+ years of experience
  • Memorial Sloan Kettering Cancer Center, New York, NY
  • Specialties include: Pancreatic cancer, hepatobiliary malignancies, neuroendocrine tumors, gastrointestinal oncology
  • Medical Degree: Trinity College Dublin, Ireland; Post-graduate training in Ireland; Fellowship in Hematology/Oncology, MSK
  • Member and Chairman of the MSK Human Research Protection Program and Institutional Review Board

• Accomplishments & Innovator

  • Spearheaded first new treatment in over a decade for treatment-naive metastatic pancreatic cancer
  • Principal Investigator of the MSK Pancreas Specialized Program in Oncology Research Excellence - one of 3 NIH-funded team science grant awards nationwide in pancreatic cancer
  • Medical journal contributions: Associate Editor for the Journal of Clinical Oncology, Senior Editor of Clinical Trials for Cancer Research Communications and Editor for Gastrointestinal Cancers, The Oncologist
  • Active clinical trial researcher of gene-based therapy, immunotherapy, PARP inhibitors, and individualized molecular therapy for pancreatic and hepatobiliary cancers.

Dr. O'Reilly is an international leader in managing complex gastrointestinal cancers and provides MSK patients access to new clinical trials and interdisciplinary expertise in one of the world's leading cancer care facilities.